NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION
FOR IMMEDIATE RELEASE
24 October 2023
EMIS GROUP PLC
("EMIS" OR THE "cOMPANY")
ADMISSION OF SHARES
On 17 June 2022, the Boards of Bordeaux UK Holdings II Limited ("Bidco") (an affiliate of Optum Health Solutions (UK) Limited) and EMIS announced that they had reached agreement on the terms of a recommended all cash offer pursuant to which Bidco will acquire the entire issued and to be issued ordinary share capital of EMIS (the "Acquisition"). The Acquisition is being implemented by means of a Court-sanctioned scheme of arrangement under Part 26 of the Companies Act 2006 (the "Scheme").
In connection with the Acquisition, and to satisfy awards held by employees of EMIS and its subsidiaries under the Company's established share option plans, which awards will vest and become exercisable upon Court sanction of the Scheme, EMIS announces that it has applied for 846,034 ordinary shares of £0.01 each in the capital of EMIS to be admitted to trading on AIM ("Admission").
Admission is expected to take place at 8.00 a.m. on 25 October 2023.
Enquiries:
| EMIS | |
| Andy Thorburn, Chief Executive Officer | +44 (0) 330 024 1269 |
| Peter Southby, Chief Financial Officer | |
| | |
| Numis (Financial adviser, corporate broker and nominated adviser to EMIS) | |
| Simon Willis | +44 (0) 207 260 1000 |
| Joshua Hughes | |
| Havish Patel | |
| | |
| MHP (PR adviser to EMIS) | +44 (0) 203 128 8572 |
| Reg Hoare | EMIS@mhpgroup.com |
| Ollie Hoare |
|
| Matthew Taylor | |
| | |
| Bidco / Optum UK | |
| Aisling Kearney | +44 7971 428266 |
| | |
| Robey Warshaw (Financial Adviser to UnitedHealth Group and Bidco) | |
| Simon Warshaw | +44 20 7317 3900 |
| Philip Apostolides | |
| | |
| FGS Global (PR Adviser to Bidco and Optum UK) | |
| John Gray | +44 20 7251 3801 |
| Amanda Healy | Optum-LON@fgsglobal.com |
Travers Smith LLP are retained as legal adviser to EMIS and Slaughter and May are retained as legal adviser to Bidco and UnitedHealth Group.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.